Health Care | Health Care Equipment & Services | Health Care Equipment & Supplies | Health Care Equipment
NYSE | Common Stock
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide.
It operates through Oncology Systems and Proton Solutions segments.
The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment.
Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software.
This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics.
The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer.
The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to itsU. S.
Oncology Network and Vantage Oncology affiliated sites of care; strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets; and collaboration with Google Cloud.
Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999.
The company was founded in 1948 and is headquartered in Palo Alto, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jan 26, 21 | 1.14 Decreased by -1.72% | 1.03 Increased by +10.68% |
| Oct 27, 20 | 1.12 Decreased by -7.44% | 1.01 Increased by +10.54% |
| Aug 2, 20 | 0.78 Decreased by -40.91% | 0.52 Increased by +51.10% |
| May 4, 20 | 0.85 Decreased by -19.05% | 0.85 Decreased by -0.54% |
| Jan 29, 20 | 1.16 Increased by +9.43% | 1.20 Decreased by -3.50% |
| Oct 23, 19 | 1.21 Increased by +4.31% | 1.21 Decreased by -0.07% |
| Jul 24, 19 | 1.32 Increased by +26.92% | 1.13 Increased by +16.42% |
| Apr 24, 19 | 1.05 Decreased by -8.70% | 1.15 Decreased by -8.52% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 20 | 778.00 M Decreased by -6.14% | 96.50 M Increased by +9.41% | Increased by +12.40% Increased by +16.57% |
| Sep 30, 20 | 2.47 B Increased by +181.49% | -192.60 M Decreased by -372.42% | Decreased by -7.78% Decreased by -196.78% |
| Jun 30, 20 | 694.30 M Decreased by -15.92% | 61.20 M Increased by +108.16% | Increased by +8.81% Increased by +147.59% |
| Mar 31, 20 | 794.50 M Increased by +1.94% | 43.20 M Decreased by -51.24% | Increased by +5.44% Decreased by -52.17% |
| Dec 31, 19 | 828.90 M Increased by +11.86% | 88.20 M Decreased by -14.53% | Increased by +10.64% Decreased by -23.60% |
| Sep 30, 19 | 878.90 M Increased by +9.64% | 70.70 M Decreased by -39.26% | Increased by +8.04% Decreased by -44.60% |
| Jun 30, 19 | 825.80 M Increased by +16.46% | 29.40 M Decreased by -59.50% | Increased by +3.56% Decreased by -65.23% |
| Mar 31, 19 | 779.40 M Increased by +6.78% | 88.60 M Increased by +21.04% | Increased by +11.37% Increased by +13.35% |